JTT SOINS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
JTT SOINS
Largest movements
- Cash +€30,961
up €30,961 (+157%), from €19,676 to €50,637
mainly Net result for the year (+€16,085) and Deferred charges and accrued income (+€8,790)
- Deferred charges and accrued income -€8,790
down €8,790 (-82.4%), from €10,672 to €1,882
- Receivables within one year -€7,634
down €7,634 (-25.7%), from €29,655 to €22,020
- Profit (loss) carried forward +€16,085
up €16,085 (+29.9%), from €53,780 to €69,865
- Tax, wage and social debts -€1,402
no longer reported in 2025 (was €1,402)
- Gross operating margin -€10,658
down €10,658 (-33.8%), from €31,573 to €20,916
- Taxes -€2,398
down €2,398 (-34.8%), from €6,902 to €4,503
- Financial income -€1,030
down €1,030 (-80.4%), from €1,282 to €252
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €60,510 | €74,865 | +€14,355 | +23.7% |
| Fixed assets | 21/28 | €508 | €326 | -€182 | -35.8% |
| Tangible fixed assets | 22/27 | €508 | €326 | -€182 | -35.8% |
| Plant, machinery and equipment | 23 | €508 | €326 | -€182 | -35.8% |
| Current assets | 29/58 | €60,002 | €74,539 | +€14,537 | +24.2% |
| Amounts receivable within one year | 40/41 | €29,655 | €22,020 | -€7,634 | -25.7% |
| Other amounts receivable | 41 | €29,655 | €22,020 | -€7,634 | -25.7% |
| Cash at bank and in hand | 54/58 | €19,676 | €50,637 | +€30,961 | +157% |
| Deferred charges and accrued income | 490/1 | €10,672 | €1,882 | -€8,790 | -82.4% |
| Total equity and liabilities | 10/49 | €60,510 | €74,865 | +€14,355 | +23.7% |
| Equity | 10/15 | €58,780 | €74,865 | +€16,085 | +27.4% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €53,780 | €69,865 | +€16,085 | +29.9% |
| Amounts payable | 17/49 | €1,731 | - | -€1,731 | |
| Amounts payable within one year | 42/48 | €1,731 | - | -€1,731 | |
| Trade debts | 44 | €329 | - | -€329 | |
| Suppliers | 440/4 | €329 | - | -€329 | |
| Taxes, remuneration and social security | 45 | €1,402 | - | -€1,402 | |
| Taxes | 450/3 | €1,402 | - | -€1,402 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38 | €182 | +€144 | +380% |
| Other operating charges | 640/8 | €116 | €292 | +€176 | +152% |
| Gross operating margin | 9900 | €31,573 | €20,916 | -€10,658 | -33.8% |
| Operating profit (loss) | 9901 | €31,419 | €20,441 | -€10,978 | -34.9% |
| Financial income | 75/76B | €1,282 | €252 | -€1,030 | -80.4% |
| Recurring financial income | 75 | €1,282 | €252 | -€1,030 | -80.4% |
| Financial charges | 65/66B | €296 | €104 | -€191 | -64.7% |
| Recurring financial charges | 65 | €296 | €104 | -€191 | -64.7% |
| Profit (loss) for the period before taxes | 9903 | €32,405 | €20,589 | -€11,817 | -36.5% |
| Income taxes | 67/77 | €6,902 | €4,503 | -€2,398 | -34.8% |
| Profit (loss) for the period | 9904 | €25,503 | €16,085 | -€9,418 | -36.9% |
| Profit (loss) for the period to be appropriated | 9905 | €25,503 | €16,085 | -€9,418 | -36.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.